SCHEMBL175205

SCHEMBL175205

O=C(Nc1cccc(C(F)(F)F)c1)Nc1cccc2c1CCN2

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.58
GRIK1 P39086 7/20 0.57
KMT2A Q03164 4/20 0.56
MEN1 O00255 3/20 0.56
MAPT P10636 2/20 0.56
HTT P42858 2/20 0.56
RAB9A P51151 1/20 0.56
NTRK1 P04629 1/20 0.55
CDK19 Q9BWU1 1/20 0.55
TRPV1 Q8NER1 2/20 0.54
ALDH1A1 P00352 1/20 0.52
GRM5 P41594 1/20 0.51
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
RXFP1 Q9HBX9 1/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175419 0.88 MAPT (0.54) KDRKMT2AMEN1MAPTHTT
SCHEMBL4569778 0.82 MEN1 (0.53) KDRKMT2AMEN1MAPTHTT
SCHEMBL173846 0.82 STING1 (0.53) KDRGRIK1KMT2AMEN1MAPT
SCHEMBL174986 0.82 KMT2A (0.52) KDRKMT2AMEN1MAPTRAB9A
Hydrochloric Acid SCHEMBL174066 0.81 KMT2A (0.51) KDRKMT2AMEN1MAPTRAB9A
SCHEMBL173797 0.81 MEN1 (0.54) GRIK1KMT2AMEN1RAB9ATRPV1
SCHEMBL175596 0.80 MEN1 (0.56) KDRKMT2AMEN1MAPTRAB9A
SCHEMBL17664319 0.79 KMT2A (0.82) KDRGRIK1KMT2AMEN1MAPT
SCHEMBL175118 0.79 RAB9A (0.58) KDRGRIK1KMT2AMEN1MAPT
SCHEMBL30101230 0.78 KMT2A (0.90) KDRGRIK1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP claimed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO claimed
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed